Minarini A - Search Results

1

Alzheimer's disease: new approaches to drug discovery.

Bolognesi ML, Matera R, Minarini A, Rosini M, Melchiorre C. Bolognesi ML, et al. Among authors: minarini a. Curr Opin Chem Biol. 2009 Jun;13(3):303-8. doi: 10.1016/j.cbpa.2009.04.619. Epub 2009 May 19. Curr Opin Chem Biol. 2009. PMID: 19467915 Review.

2

Affinity and selectivity at M2 and M3 muscarinic receptor subtypes of cyclic and oxygenated analogues of 4-DAMP.

v Tumiatti, Recanatini M, Minarini A, Melchiorre C, Budriesi R, Bolognesi ML. v Tumiatti, et al. Among authors: minarini a. Farmaco. 1992 Sep;47(9):1133-47. Farmaco. 1992. PMID: 1300119 No abstract available.

3

Further investigation on methoctramine-related tetraamines: effects of terminal N-substitution and of chain length separating the four nitrogens on M2 muscarinic receptor blocking activity.

Minarini A, Budriesi R, Chiarini A, Melchiorre C, Tumiatti V. Minarini A, et al. Farmaco. 1991 Oct;46(10):1167-78. Farmaco. 1991. PMID: 1815579

4

Molecular properties of the histamine H2-receptor. Covalent inhibition by tetraamine disulfides.

Chiarini A, Minarini A, Budriesi R, Melchiorre C. Chiarini A, et al. Among authors: minarini a. Farmaco. 1990 Sep;45(9):1001-11. Farmaco. 1990. PMID: 1980817

5

In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors.

Chiarini A, Budriesi R, Bolognesi ML, Minarini A, Melchiorre C. Chiarini A, et al. Among authors: minarini a. Br J Pharmacol. 1995 Apr;114(7):1507-17. doi: 10.1111/j.1476-5381.1995.tb13378.x. Br J Pharmacol. 1995. PMID: 7606355 Free PMC article.

6

Binding profile of the selective muscarinic receptor antagonist tripitramine.

Maggio R, Barbier P, Bolognesi ML, Minarini A, Tedeschi D, Melchiorre C. Maggio R, et al. Among authors: minarini a. Eur J Pharmacol. 1994 Aug 16;268(3):459-62. doi: 10.1016/0922-4106(94)90075-2. Eur J Pharmacol. 1994. PMID: 7805774

7

Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.

Minarini A, Bolognesi ML, Budriesi R, Canossa M, Chiarini A, Spampinato S, Melchiorre C. Minarini A, et al. J Med Chem. 1994 Sep 30;37(20):3363-72. doi: 10.1021/jm00046a021. J Med Chem. 1994. PMID: 7932564

8

Synthesis and biological activity of some methoctramine-related tetraamines bearing a 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-one moiety as antimuscarinics: a second generation of highly selective M2 muscarinic receptor antagonists.

Melchiorre C, Bolognesi ML, Chiarini A, Minarini A, Spampinato S. Melchiorre C, et al. Among authors: minarini a. J Med Chem. 1993 Nov 12;36(23):3734-7. doi: 10.1021/jm00075a032. J Med Chem. 1993. PMID: 8246244 No abstract available.

9

Search for selective antagonists at alpha 1-adrenoreceptors: neutral or negative antagonism?

Melchiorre C, Bolognesi ML, Budriesi R, Chiarini A, Giardinà D, Minarini A, Quaglia W, Leonardi A. Melchiorre C, et al. Among authors: minarini a. Farmaco. 1998 Apr;53(4):278-86. doi: 10.1016/s0014-827x(98)00022-6. Farmaco. 1998. PMID: 9658586 Review.

10

Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor.

Barbier P, Colelli A, Bolognesi ML, Minarini A, Tumiatti V, Corsini GU, Melchiorre C, Maggio R. Barbier P, et al. Among authors: minarini a. Eur J Pharmacol. 1998 Aug 21;355(2-3):267-74. doi: 10.1016/s0014-2999(98)00485-3. Eur J Pharmacol. 1998. PMID: 9760041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters